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Abstract

Influenza virus binds to cell surface sialic acid receptors, and following endocytosis fuses with the endosome membrane at low pH.
Whether sialic acid plays a role in the virus-cell membrane fusion step is not known. We investigated the effect of the removal of cell
membrane sialic acid on the fusion activity of influenza virus ( A / P R / 8 / 3 4 strain) toward human T lymphocytic leukemia (CEM) cells
at low pH. Fusion was monitored by fluorescence dequenching of octadecylrhodamine incorporated in the virus membrane. Removal of
sialic acid by neuraminidase resulted in a drastic reduction in both viral binding and fusion. The association of the virus with
neuraminidase-treated cells was enhanced at pH 5, compared to that at neutral pH, probably due to the unfolding of the hemagglutinin and
the resulting increase in viral surface hydrophobicity, but the fusion capacity of the virus was reduced significantly. The results were
analysed with a mass-action kinetic model which could explain and predict the kinetics of fusion. Our results indicate that binding of
influenza virus to sialic acid residues on the cell surface leads to rapid and extensive fusion and partially inhibits the low pH-induced viral
inactivation.
Keywords: Influenza virus; Sialic acid; Membrane fusion; Membrane binding; CEM cell; Neuraminidase; Fluorescence

1. Introduction

Cell surface sialic acid residues are considered to be the
primary receptors for influenza virus [ 1-4]. Initial binding
of the virus is followed by endocytosis, and fusion of the
viral membrane with the endosomal membrane upon acidification of the endosome lumen [5-7]. Structural studies
of the influenza hemagglutinin have shown sialic acid as
the main component of the cellular receptor for the virus
[8]. An indirect role for sialic acid in helping sialoglycoproteins attain a critical structure has also been proposed

* Corresponding author. Fax: + 1 (415) 9296564.
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SSDI 0 0 0 5 - 2 7 3 6 ( 9 5 ) 0 0 0 6 7 - 4

[9]. Whether the cell membrane sialic acid is also involved
in the membrane fusion reaction is not known. Previous
studies on the fusion of influenza virus with liposomes
have indicated that the presence of ganglioside Go1 a increases the rate constant of adhesion, but not that of fusion
[10], while studies utilizing liposomes containing varying
amounts of gangliosides have shown an optimal surface
concentration for virus-liposome fusion [11]. It has been
suggested that the interaction of gangliosides GT1 b or Grab
with influenza virus hemagglutinin causes an increase in
the fluidity of the viral envelope, thereby promoting fusion
with target membranes [12]. We previously examined the
low pH-induced fusion of influenza virus with the plasma
membranes of living CEM cells as a model to study the
fusion of the virus with endosome membranes [13]. Here
we have utilized this model system to investigate the role
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of cell membrane sialic acid in the fusion reaction of
influenza virus with cellular membranes.

protein concentration of the labeled virus was determined
by the Lowry assay.
2.4. Fusion o f R18 labeled influenza virus with CEM cells

2. Materials and methods
2.1. Materials

Influenza virus, A / P R / 8 / 3 4 (H1NI) strain was obtained from SPAFAS (Preston, CT). The virus was grown
for 48 h at 37°C in the allantoic cavity of 11-day-old
specific pathogen-free embryonated eggs, purified by discontinuous sucrose density gradient centrifugation and
stored at - 7 0 ° C in phosphate buffered saline. Trypsin,
trypsin inhibitor, neuraminidase (from Vibrio cholerae, 1
unit/ml specific activity), endoglycosidase H (1 unit/ml
specific activity) and octaethyleneglycol dodecyl ether
(C~2E 8) were purchased from Calbiochem (San Diego,
CA). Tes buffer and NaC1 were from Sigma (St. Louis,
MO). Proteinase K was obtained from Boehringer-Mannheim, endoglycosidase F (200 units/ml specific activity)
from Oxford GlycoSystems (Rosedale, NY), and octadecylrhodamine B chloride (R18) from Molecular Probes
(Eugene, OR).
2.2. Cells

CEM cells (obtained from the UCSF Cell Culture Facility) were maintained in RPMI 1640 medium containing 25
mM Hepes buffer, supplemented with 10% foetal bovine
serum (FBS) and antibiotics. The cells were grown in T-75
flasks under a 5% CO 2 atmosphere at 37°C up to a cell
density of 1. 106-1.5 • 106/ml. The cells were harvested
by centrifugation at 180 X g for 8 min at room temperature, washed twice in Dulbecco's PBS, and once in phenol
red-free RPMI 1640 containing 25 mM Hepes buffer (pH
7.4) (Medium A). The cells were resuspended in the latter
buffer at a stock cell density of 108/ml and kept on ice in
polypropylene centrifuge tubes until use the same day. Cell
viability was determined by Trypan blue exclusion and
was routinely above 95%.
2.3. Virus labeling

The virus was labeled with R18 as described previously
[14]. A 4.8 /zl aliquot of a 3.12 /xmol/ml ethanolic
fluorophore solution was injected under vortex mixing into
a viral suspension containing 2 mg of viral protein/ml.
The final concentration of added probe corresponded to
approx. 4 mol% of total viral lipid, and that of ethanol was
less than 1% ( v / v ) . The mixture was incubated in the dark
for 0.5-1 h at room temperature. R18-1abeled virus was
separated from uninserted fluorophore by chromatography
on Sephadex G-75 (Pharmacia, Uppsala, Sweden) using 10
mM Tes, 150 mM NaCl (pH 7.4) as elution buffer. The

Fusion was monitored continuously with the RI8 fluorescence assay [13-16]. Fusion was initiated either by
rapid injection of R18-1abeled virus (4 /~g viral protein)
into a cuvette containing the cell suspension (4.107 cells)
at pH 5, or by lowering the pH (to 5) of the suspension of
cells and virus preincubated at pH 7.4. The final incubation volume was always 2 ml Medium A and the pH was
measured at the end of each experiment with a Beckman
pH meter. The fluorescence scale was calibrated such that
the initial fluorescence of the R18-1abeled virus and cell
suspension was set at 0% fluorescence. The value obtained
by lysing the virus and cellular membranes after each
experiment with C I2E8 (at a final concentration of 2 mM),
was set to 100% fluorescence. Fluorescence measurements
were performed in a Spex Fluorolog 2 fluorometer using
the front-face configuration in the emission channel, with
excitation at 560 nm and emission at 590 nm, using 5 and
25 mm slits in both monochromators. A high-pass filter
(50% transmission at 590 nm; Schott Glass OG590,
Melles-Griot) was placed between the cuvette and the
emission monochromator. The sample chamber was
equipped with a magnetic stirring device and the temperature was controlled with a thermostatted circulating water
bath. Some experiments were also carried out using a
Perkin-Elmer LS-5B fluorometer, operated with a Softways (Moreno Valley, CA) computer program.
2.5. Binding and cell association

Fluorescently labeled influenza virus was incubated with
CEM cells in identical amounts as in the fusion experiments, in a final volume of 2 ml Medium A, either for 5
min at 37°C or for 30 min at 0°C with stirring. Cell
association experiments were carried out in the same way
but at pH 5, with or without virus-cell prebinding at pH
7.4. Incubations were carried out either at 37°C or 0°C
and for 1 min or 5 min at pH 5, as described under
Results. The cells were sedimented by centrifugation at
4°C for 7 rain at 180 X g and the fluorescence was
measured at 37°C in the supernatant and pellet following
detergent lysis. In some experiments the virus was precentrifuged at 180 X g for 7 rain to eliminate any aggregated virions, and exclude the possibility of virus co-pelleting with the cells.
2.6. Enzymatic treatment

CEM cells (4. 10 7) were
enzymes, trypsin (0.0025%
proteinase K (0.01% ( w / v )
(0.005 and 0.05 unit/ml),

incubated with the various
( w / v ) , 0.05%, and 0.1%),
and 0.05%), neuraminidase
endoglycosidase H (0.005
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u n i t / m l ) and endoglycosidase F (1 u n i t / m l ) in a final
volume of 2 ml Medium A at 37 ° C for 20 min. Following
enzymatic treatment, cells were placed on ice for 5 min to
stop the reaction, except for trypsin where the reaction was
terminated by adding a twofold molar excess of trypsin
inhibitor. The cells were centrifuged at 4 ° C for 7 min at
180 × g, washed once in cold Medium A, resuspended in
the same medium and kept on ice until use. Control cells
were treated in parallel under the same conditions in
Medium A without the enzyme. The use of either 0.005 or
0.05 u n i t / m ] neuraminidase produced the same effect on
both virus binding and fusion, and higher enzyme concentrations did not result in further inhibition. Cell viability
was shown not to be affected by the enzymatic treatment
at the enzyme concentrations used.

divided the time t into small segments and assumed a
linear increase in B with time in Eq. (2).

3. R e s u l t s

3.1. Dependence of influenza virus fusion activity on neuraminidase pretreatment of CEM cells
The fluorescence dequenching of R18 has been used as
a reliable indicator of v i r u s - c e l l fusion in numerous systems [13,16,18-23]. We investigated the role of cell surface sialic acid residues in influenza virus fusion with
CEM cells using this assay. The time-course of R18
fluorescence dequenching during the incubation of influenza virus with neuraminidase-treated and untreated
(control) CEM cells is shown in Fig. 1. In preliminary
experiments the toxic effects of a range of neuraminidase
concentrations on cells were determined by Trypan blue
exclusion. A concentration of neuraminidase was chosen
(0.005 u n i t / m l ) which was well below the toxic limit.
Concentrations of neuraminidase 10-fold higher than the
chosen concentration, did not cause any further inhibition
of binding at 37 ° C, indicating that the significant sialic
acid residues (i.e, those relevant to virus binding) had been
removed by the lower enzyme concentration utilized in
most of our binding and fusion studies.
In one set of experiments, the virus was allowed to bind
to the cells for 5 rain at 37°C (pH 7.4), and the pH was
lowered to 5 to induce membrane fusion (Fig. 1A). Neuraminidase pretreatment of the cells caused a drastic reduction in virus fusion activity (curve b). In the other set of
experiments, the virus was bound to the cells for 30 min at
0 ° C (pH 7.4), and the unbound virus was removed from
the medium before lowering the pH (Fig. I B). Under these

2.7. Analysis of fusion kinetics
The analysis of prebinding experiments was based on a
slight modification o f the procedure in Nir et al. [17]. The
fraction o f the virus prebound to the cells at neutral pH is
denoted by B 1, whereas B 2 denotes the fraction of virus
associated with the cells at the end of the incubation period
at low pH. An expression for the fusion rate constant, f
( s - J ) , that accounts for inactivation is given by

f(t) =f(0)[exp(-yt)

+ y2(l - e x p ( - y t ) ) / y ]

(l)

in which t is the time and y = yl + "Y2. In Eq. (1) y~ and
3'_, represent forward and reverse rate constants of inactivation. In our analysis we set Y2 = 0. If B is constant and
3',, = 0, the fraction of fused virus, F(t), is given by

F ( t ) = [1 - e x p [ f ( O ) ( e x p ( - y t )

- 1)/T]B

(2)

In the analysis of virus fusion with neuraminidase-treated
cells, where B 2 was significantly larger than B~, we
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Fig. I. Effect of neuraminidase pretreatment of CEM cells on influenza virus fusion activity. (A) Influenza virus (2 /.*g viral protein/ml) was added to
4 • 1 0 7 control (a) or neuraminidase-treated (b) CEM cells in a final volume of 2 ml, and Rl8 dequenching was monitored for 5 rain at 37° C and pH 5,
following virus-cell preincubation for 5 min at 37° C. (B) Influenza virus (2 /zg viral protein/ml) was added to 4 • 1 0 7 control (c) or neuraminidase-treated
(d) CEM cells in a final volume of 2 ml, and incubated for 30 min at 0° C. The unbound virus was removed by centrifugation in the cold, and RI8
dequenching was monitored for 5 min at 37° C and pH 5. The symbols represent the values calculated by using the mass action kinetic model for control
( [] ) and neuraminidase-treated cells ( II ).
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conditions, the fusion activity of the bound virus was also
inhibited significantly in enzyme pre-treated cells. In control cells, these two experimental approaches yielded similar values for the initial rates of fusion, as well as for the
extents of fusion (Fig. 1, curves a and c). In treated cells,
however, the decrease in the initial rate and extent of
fusion was not as dramatic when the unbound virus was
removed (curve d).
We examined the time-course of virus-cell fusion by a
mass-action kinetic analysis [17]. The fusion (f) and inactivation (7) rate constants given in Table 1 resulted in fits to
the curves in Fig. 1 shown by the squares. In the case of
neuraminidase pretreatment of cells, the data were fit best
by invoking a decrease in f and an increase in 7, compared
to the control cells (Table 1). When the virus was preincubated with the cells at 37 ° C, removal of sialic acid resulted in a 5-fold reduction in f, and a similar increase in
7. Preincubation in the cold resulted in a similar pattern.
We also investigated how the prebinding of the virus to
the cells at neutral pH and 37 ° C, before initiation of the
fusion reaction, affects the extent of fusion, both for
neuraminidase-treated and control cells (Fig. 2). When the
virions were prebound to the normal cells, the extent of
fusion was higher compared to the case of no prebinding
(Fig. 2, open bars). In contrast, for neuraminidase-treated
cells, a slight decrease in the extent of fusion was observed
with prebinding (striped bars).
Enzymes other than neuraminidase that were tested did
not affect the kinetics of virus-cell fusion, at the concentrations of enzyme and incubation conditions that were
necessary to retain cell viability (data not shown), and
were therefore not examined further.
3.2. Virus binding and association to untreated and neuraminidase-treated cells

To further characterize the role of sialic acid in the
fusion activity of influenza virus, experiments on virus
binding and association to untreated (control) and neuraminidase-treated cells were performed under several experimental conditions. Fig. 3 shows that pretreatment of
cells with neuraminidase at the same concentration as the
fusion experiments resulted in a significant decrease in
virus binding at pH 7.4. When binding experiments were
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Fig. 2. Effect of neuraminidase pretreatment of CEM cells on the extent
of fusion of influenza virus, with or without viral prebinding to the cells.
Influenza virus (2 /~g viral protein/ml) was added to 4.107 control (open
bars) or neuraminidase-treated (striped bars) CEM cells in a final volume
of 2 ml at 37 ° C, and the extent of R18 fluorescence dequenching was
measured after 5 min incubation at pH 5, with or without prebinding of
the virus to the cells. In the case of viral prebinding, the virus was
incubated with ceils for 5 min at neutral pH before lowering the pH to 5.
In the absence of viral prebinding, the pH of the cell suspension was
adjusted to 5 just prior to addition of virus. Values represent means of at
least 5 experiments 5: standard deviation.

carried out at 0°C for 30 min, the decrease in virus
binding due to enzymatic treatment (24% of control) was
not as pronounced as that observed when the virus was
allowed to bind to pretreated cells at 37 ° C for 5 min (70%
of control). In contrast, when the cells were pretreated with
a higher concentration of neuraminidase, a similar reduction in binding was observed at both temperatures (Table

2).
In addition to determining virus binding to cells at
neutral pH, we measured the amount of cell-associated
virus after an initial 5 min prebinding at neutral pH and
subsequent reduction of the pH to 5. These experiments
measure the total amount of virus bound to or fused with
the cell membrane, 1 min or 5 min after the reduction of
the pH. Following a 5 min incubation at low pH, 81.8% of
the virions became associated with the control cells, and
61.7% were associated with neuraminidase-treated cells
(Fig. 4). It is interesting to note that virus association with

Table 1
Effect of neuraminidase pretreatment of CEM cells on fusion and inactivation rate constant of influenza virus
Preincubation condition a

Cells b

Fusion rate constant,
f (s - 1)

Inactivation rate constant,
y ( s - I)

Lag time
(s)

37 ° C for 5 min

Control
NA-treated
Control
NA-treated

0.15
0.03
0.13
0.033

0.01
0.05
0.02
0.058

0
0
0.7
0

0° C for 30 min, unbound virus removed

a In each case, influenza virus was preincubated with the indicated cells as described, and the pH was subsequently lowered to 5, at 37 ° C, to induce
fusion.
b CEM cells were either treated with 0.005 unit/ml neuraminidase (NA), as described in Section 2, or mock-treated with buffer.
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Fig. 3. Effect of neuraminidase pretreatment of CEM cells on influenza
virus-cell binding. Influenza virus (2 /zg viral protein/ml) was added to
4.107 control (shaded bars) or neuraminidase-treated CEM cells (striped
bars) in a final volume of 2 ml at pH 7.4, and incubated at 37° C (5 rain)
or at 0° C (30 min). Virus-cell binding was determined from fluorescence
values in the pellet and supernatant, after addition of C ~2Es to dequench
the RI 8 (see Section 2). Values represent means of at least 5 experiments
+ standard deviation.

the n e u r a m i n i d a s e - t r e a t e d cells was m u c h larger than that
e x p e c t e d f r o m fusion and binding results ( c o m p a r e with
Figs. 1-3). The results in Fig. 4 also indicate that v i r u s - c e l l
association after a 1 min incubation at p H 5 was 87% o f
that obtained after a 5 min incubation for control cells, and
67% for neuraminidase-treated cells. The time course of
cell association closely reflected the kinetics o f virus fusion with control cells, where m o s t o f the fusion process
was c o m p l e t e d after 1 min. F o r neuraminidase-treated
cells, h o w e v e r , the a m o u n t o f virus that was cell-associated at p H 5 exhibited a time d e p e n d e n c e that did not

Table 2
Influenza virus binding to CEM cells: effects of temperature and neuraminidase concentration
Preincubation
conditions a

Incubation
temperature (° C)

Binding b
(% fluorescence)

Control

0
37
0
37
0
37

84.5 [3.1 ]
77.8 [0.5]
37.7 [2.0]
36.6 [1.0]
62.9 [0.9]
39.4 [1.8]

NA (0.05 unit/ml)
NA (0.005 unit/ml)

a CEM cells were treated with either 0.05 or 0.005 unit (U)/ml neuraminidase (NA), as described in Section 2, or mock-treated with buffer
(control).
b Influenza virus (pre-centrifuged at 180× g) was added to 4- 107 control
or neuraminidase-treated CEM cells, at a concentration of 2 p,g viral
protein/ml in a final volume of 2 ml at pH 7.4, and incubated at 37° C (5
min) or at 0°C (30 min). Virus-cell binding was determined from
fluorescence values in the pellet and supernatant, after addition of CI2 E8
to dequench the RI8 (see Section 2). The numbers represent the average
value of duplicate determinations. The numbers in square brackets show
the spread of the data in % of virions bound.

2O

0

1 rain

5 min

Fig. 4. Effect of neuraminidase pretreatment of CEM cells on influenza
virus-cell association at low pH. Influenza virus (2 p~g viral protein/ml)
was added to 4.107 control (threaded bar) or neuraminidase treated CEM
cells (shaded bars) in a final volume of 2 ml at 37°C. After 5 min
incubation at pH 7.4, the virus-cell suspension was acidified to pH 5 and
further incubated for 1 or 5 min. The fraction of cell-associated virus was
determined by measuring the fluorescence in the pellet and the supernatant, after addition of CI2E 8 to dequench the RI8 (see Section 2).
Values represent means of at least 5 experiments + standard deviation.

correlate with the viral fusion activity under the same
conditions (see Figs. 1 and 2).
The observation that the percentage o f cell associated
virus at low p H (Fig. 4) closely reflected the percentage o f
fusion at 1 or 5 min (Fig. 1), indicates that most of the
virus that had b o u n d to the control cells u n d e r w e n t fusion.
This result also indicates that virions did not merely
c o - s e d i m e n t non-specifically with the cells during centrifugation f o l l o w i n g a low p H treatment. If the virus had
aggregated and pelleted with the cells, the percentage of
cell-associated virus w o u l d have been m u c h larger than the
percentage of fused virus. Previous light scattering and
absorbance m e a s u r e m e n t s had s h o w n that virions did not
aggregate at neutral or low p H under the experimental
conditions e m p l o y e d [10,24]. The observations that (i)
neuraminidase treatment o f cells caused a large reduction
o f virus binding at 3 7 ° C (Fig. 3), and that (ii) essentially
the s a m e binding results were obtained w h e n the virus
preparation was pre-centrifuged before being incubated
with the cells (Table 2 and data not shown), indicate that
the virus did not aggregate or sediment non-specifically at
neutral pH.
The higher fraction o f the virus associated with neuraminidase-treated cells at p H 5, c o m p a r e d to neutral pH,
could be the result o f the increased hydrophobicity o f the
viral H A at low pH [25,26]. The increased hydrophobicity
could arise f r o m the dissociation o f the g l o b u l a r heads o f
the H A trimers, or f r o m e x p o s u r e o f the hydrophobic H A 2
N-terminal fusion peptide [25,27,28]. To d e t e r m i n e w h e t h e r
the e n h a n c e d binding o f the virus to treated cells at low p H
could be due to the unfolding o f the globular heads, cell
association experiments were carried out under conditions
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where the kinetics of unfolding is very slow, i.e., at 0 ° C
[27]. Cell association measured in the cold after a 5 min
incubation at neutral pH, was about 3-fold higher for
control cells than for treated cells (data not shown). However, upon further incubation for 5 min at 0 ° C at pH 5, the
fraction of virus bound was not significantly increased,
both for treated and control cells (data not shown), in
contrast to the results of virus-cell association at 37°C
(Fig. 4). Thus, the lack of an increase in virus association
with cells in the cold upon lowering the pH, particularly in
the case of neuraminidase-treated cells, is consistent with
the lack of (or very limited) unfolding of HA at low
temperature. Although the fusion peptide is thought to be
at least partially exposed at low temperatures [27,28], it is
apparently not sufficient to enhance the binding of the
virus to the cell membrane at low pH. The binding of the
A / P R / 8 / 3 4 strain of influenza virus to liposomes at pH
5 was also inhibited at 4 ° C, compared to the binding at
37 ° C, despite the partial exposure of the fusion peptide
[281.

4. Discussion
Several observations indicate that cell surface sialic acid
residues modulate the fusion activity of influenza virus, as
well as mediating its binding to the cell surface: (i) The
fusion of virions (at 37 ° C) prebound to neuraminidasetreated cells (at 0 ° C) is inhibited compared to fusion with
control cells (Fig. lb). Under these conditions where the
unbound virions were removed, the receptor binding step
is bypassed, and the fluorescence dequenching provides a
measure of the fusion of virions which were already bound
to the cells, possibly via non-sialic acid receptors. (ii) The
fusion rate constant is decreased significantly when the
sialic acid receptors are removed (Table 1). (iii) Prebinding
of the virus to cells at 37 ° C does not enhance fusion with
cells treated with neuraminidase, in contrast to control
cells (Fig. 2). We propose that in cells from which sialic
acid residues have been removed, virus binding occurs at
sites on the cell surface where fusion is unfavorable.
Alternatively, the virus may be able to bind to fusion sites,
but it does not exhibit the proper orientation to trigger
fusion, thus becoming inactivated at low pH [13,17,29].
When the cell surface sialic acid has been removed, the
viral neuraminidase would also be unable to dislocate the
virion from a binding site unfavorable for fusion. The
observation that trypsin or proteinase K treatment did not
have a significant effect on the fusion kinetics suggests
that the binding site for influenza virus on CEM cells may
be gangliosides rather that glycoproteins. Although further
studies are needed to ascertain this hypothesis, previous
studies have also implicated gangliosides as influenza virus
receptors [1 ]. Furthermore, gangliosides have been shown
to act as cellular receptors for Sendai virus, a paramyxovirus [30].

The initial kinetics of fusion with neuraminidase-pretreated cells depends on the conditions of preincubation of
the virus and the cells, being apparently slower with
preincubation at 37°C (Fig. I A, curve b) than with preincubation at 0 ° C followed by removal of the unbound virus
(Fig. 1B, curve d). The results in Fig. 3 indicate, however,
that the amount of virus bound at 0°C is considerably
greater than that at 37 ° C, thus contributing to the more
rapid kinetics observed. Indeed, the kinetic parameters
describing the fusion reaction in both cases turn out to be
the same, within the estimated uncertainty (Table 1). The
kinetic parameters obtained for both incubation conditions
were also similar in the neuraminidase-treated cells. No lag
times were observed except for the case of preincubation
of control cells on ice, where a lag time of 0.7 s gave the
best fit to the data.
Viral fusion studies using liposomes as target membranes have shown that influenza virus fuses readily with
lipid membranes of a variety of compositions in a pH-dependent manner [10,17,24,27,31,32]. It is interesting to
note that although the presence of sialic acid-containing
receptors in the liposomal membrane is not required for
fusion of influenza virus, it enhances virus binding [10].
Although ganglioside GD,a had little effect on the fusion
rate constants or on the final extents of fusion, it enhanced
3-fold the rate constant of adhesion for influenza virus
[10]. Our results also show that influenza virus binding is
dramatically reduced upon pretreatment of target cells with
neuraminidase. However, the mass action kinetic model
shows that, in contrast to virus-liposome fusion, removal
of sialic acid also leads to a significant decrease in the
fusion rate constant (see Table 1). The results of Stegmann
et al. [27] suggested that gangliosides incorporated in
zwitterionic liposomes may enhance the formation of an
active fusion complex, thus leading to an increase in the
rate of the actual fusion process. Studies with influenza
virus prebound to planar bilayers with or without gangliosides suggested that the rate of membrane fusion is enhanced by the presence of gangliosides [33]. The kinetics
of fusion pore formation in planar bilayers incubated with
influenza virus-infected cells was also found to be affected
by gangliosides in the target membrane [34]. Recently
Alford et al. [11] showed that the presence of GD,a could
promote the initial kinetics of lipid mixing between influenza virus and large DOPC liposomes containing 2.5 or
5 mol% GD~a, whereas with liposomes containing 10 or 15
tool% of the ganglioside the initial kinetics was slower.
They also demonstrated that the presence of the ganglioside in liposomes reduced significantly the low pH inactivation of the virus which was preincubated with an excess
of liposomes at neutral pH. In our system we have only
observed enhancement in the fusion activity of the virus
when the cell surface sialic acid was intact, which suggests
that the sialic acid content on the surface of control CEM
cells is in the optimal range for influenza virus fusion.
The results presented in Fig. 2 indicate that the extent
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of influenza virus-cell fusion is higher when the virions
are prebound to cellular sialylated membrane receptors,
since the virus can start fusing immediately upon acidification of the medium. Our previous studies [13,17,18] have
shown that the rate constants of inactivation ( y ) at pH 5
for the virus prebound to CEM cells and several other cell
lines are significantly lower than the values for the unbound virus, thus contributing to the enhanced extent of
fusion in the case of prebound virus. The fact that prebinding does not enhance fusion in the case of neuraminidasetreated cells suggests that the presence of sialic acid
residues on control cells is essential to confer biologically
relevant viral fusion activity. In neuraminidase-treated cells,
fusion may exhibit some nonspecific and nonphysiological
nature, and, therefore, virus binding to predominantly
non-sialic acid sites will not play an important role in the
fusion process. In addition, virus prebound to neuraminidase-treated cells may undergo more inactivation
when the pH is lowered than virus bound to control cells.
Our experiments on virus binding to cells at neutral pH
(Fig. 3) stress the importance of sialic acid residues on the
cell surface as primary receptors for influenza virus. Although the amount of binding is similar at 37 ° C and 0 ° C
for control cells, binding is higher at 0°C for the neuraminidase-treated cells. These results suggest that the degree of reversibility in virus binding at 37°C is more
pronounced in the treated cells than in the control cells,
since the rate constant of dissociation is generally very
small at low temperatures [35]. However, when cells are
pretreated with a higher concentration of neuraminidase,
similar levels of binding are observed at 0°C and 37°C
(Table 2). On the other hand, pretreatment of cells with
either the high or low concentration of neuraminidase
resulted in similar values for virus fusion activity (data not
shown), consistent with the similar levels of virus binding
at 37 ° C (Table 2). It is likely that following treatment with
the lower concentration of neuraminidase some sialic acid
residues remain on the cell surface, which can be removed
by the viral neuraminidase at 37°C (but not at 0 ° C, since
the enzyme would be expected to be inactive at this
temperature). This in turn would cause the observed reduction in binding to the neuraminidase-treated cells at 37 ° C,
compared to that at 0 ° C. At 0 ° C, there would be considerable binding to the remaining sialic acid receptors (Fig. 3).
This interpretation, however, does not explain why the
viral neuraminidase does not reduce binding to untreated
cells. It is possible that removal of some sialic acid
residues by the neuraminidase treatment exposes new sialic
acid moieties susceptible to the viral neuraminidase. In an
alternative or complementary scenario, clustering of the
remaining sialic acid-bearing residues in the cold may
provide favorable binding sites for the virus; the dispersal
of these receptor sites at 37 ° C may reduce the affinity of
the virions for the cell surface. In the case of cells treated
with the higher concentration of neuraminidase, however,
the virus would not be able to remove any further sialic
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acid residues at 37 ° C. Thus, the level of binding at 37 ° C
and 0 ° C would be similar. In this case, even the clustering
of receptors in the cold would not be sufficient to mediate
the higher level of binding, since more of the sialic acid
residues would have been removed.
The extensive association of influenza virus with neuraminidase-treated cells at low pH (Fig. 4), without efficient fusion (Fig. l) suggests that the virus binds nonspecifically to treated cells under these conditions, probably due to an increase in virus surface hydrophobicity as a
result of the dissociation of the globular heads of HA
trimers and protonation of acidic amino acids [25,26]. The
observation that the fluorescence of the virus associated
with neuraminidase-treated cells is greatly quenched, while
that of the virus associated with control cells is essentially
dequenched (data not shown) supports this view. The
results of these experiments also provide evidence that the
R18 in the viral membrane does not undergo molecular
exchange or transfer under low pH conditions, despite
extensive binding to the plasma membrane. If molecular
probe transfer had occurred, the large fraction of virus
associated with treated cells at low pH should have resulted in fluorescence dequenching. This provides supporting evidence for our previous conclusion that the increase
of R18 fluorescence upon incubation of influenza virus
with CEM cells at low pH was mainly due to fusion [13].
In summary, our results demonstrate that the presence
of sialic acid-containing receptors is required for both
efficient binding and fusion of influenza virus with CEM
cells. In cells pretreated with neuraminidase, binding of
influenza virus at neutral pH is drastically reduced; at
mildly acidic pH cell association is enhanced, probably
due to an increase in virus surface hydrophobicity, but
most of the virions do not engage in fusion. Thus, influenza virus is only able to fuse efficiently at low pH
without becoming significantly inactivated when it is bound
to sialic acid-containing receptors. Therefore, it might be
suggested that in the absence of sialic acid residues in
target cells, the kinetics and extent of fusion of influenza
virus are low and nonspecific due to an inefficient and
nonspecific binding.
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